Skip to Content
  • Alnylam Breaks Through

    As a pioneer in RNAi therapeutics, Alnylam has really had some ups and downs over the years (some of them chronicled on this blog). Today would be one of the &# Read More
  • Bacteria Can Make Tumors Worse

    Since the topic of bacteria effects on human disease came up here just the other day, I wanted to point out a new article that comes at this idea from a differe… Read More
  • Tie Your Crystals Into Knots

    Chemists love crystals. We don’t do as much recrystallization as we used to, since there are higher-throughput (and less labor-intensive) ways of purifyin… Read More
  • It Costs More Than This

    Here’s another paper on the cost to develop a new drug, a topic about which, I’m convinced, debate will never end. This one is designed as a respons… Read More
  • Allergan Pulls A Fast One

    Friday brought news of a drug-company maneuver that I had never heard of, and didn’t even realize was possible. First, a bit of background; the stage need… Read More
  • Allow Me to Peruse Your Grant

    This is one that I certainly hadn’t heard of until a few days ago. According to this article, academic scientists are using the Freedom of Information Act… Read More
Page 1 of 1212345...10...Last »